M2WENTY

What M2WENTY does

M2WENTY (엠투웬티, DBA M20) is a South Korean smart healthcare company founded in 2013 that develops and commercializes CMB (Core Muscle Booster) medium-low frequency Electrical Muscle Stimulation (EMS) technology. Its core technical claim centers on a proprietary carrier-frequency method that loads low-frequency signals (1-100Hz) onto medium-frequency carriers (2,000-6,000Hz), enabling deep muscle penetration and automatic contraction/relaxation without joint strain or skin irritation — a method it states is not replicated by conventional low-frequency EMS devices. The technology is grounded in NASA astronaut muscle preservation research and protected by 13+ registered patents including a silver fabric conductor and an FPGA-based muscle stimulation controller.

The company operates a diversified hardware-and-services model spanning consumer fitness, medical, and pet health applications. Its product line includes MYO HOME (FDA-approved 27-inch smart mirror), MYO PRO (43-inch commercial all-in-one EMS and body composition device), MYO SUIT (full-body 16-zone wearable EMS), MYO LEGGINGS, MYO BAND (pain relief), MYO PET (FDA CLASS2-approved pet patella luxation device), and Miracle20 Play (portable 21.5-inch device). Revenue comes from hardware sales, B2B equipment leasing via the MYO Lease program (free installation in exchange for usage-fee revenue share), subscription/usage fees (including contactless KakaoTalk-based PT), and channel partnerships. Customer segments include health-conscious consumers, elderly and mobility-impaired patients (sarcopenia prevention, post-surgery muscle atrophy), fitness centers and rehabilitation facilities, hospitals, and — via the GLP-1 obesity drug clinical trials initiated in 2026 — patients on obesity medications experiencing muscle loss.

M20 is pursuing aggressive international expansion through channel partnerships: Ceragem US (with its own LA subsidiary), InBody for global body composition integration, Meituan Dianping for China (~700M platform members), six European country distributors, and an MOU with Suffolk Group for the UAE. Strategic research collaborations include KSB Twogen (joint Phase II trials for muscular atrophy pharmaceutical + device combos) and a March 2026 Scientific Advisory Board agreement with Johns Hopkins Medical School. The company is pursuing a KOSDAQ listing and conducted a ₩1.55 billion third-party stock issuance in December 2025 via debt-to-equity conversion. It remains a privately-held corporation led by CEO Kim Jin-gil (김진길).

Name

M2WENTY

Legal name

주식회사 엠투웬티 (Mtwenty Co., Ltd.)

Website

https://myomirror.com

Company type

Private

Founded year

2013

Operating status

Operating

Short description

M2WENTY (M20) is a South Korean smart healthcare company developing proprietary medium-low frequency CMB EMS technology for muscle stimulation, with an FDA-approved smart mirror product line serving consumers, hospitals, rehabilitation centers, fitness facilities, and pet health markets across 7+ countries.

Ownership category

akta.pro rank

Product category

Smart Healthcare EMS Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

• EMS muscle stimulation devices
• Smart healthcare platform
• Medical EMS equipment
• Muscle atrophy rehabilitation
• EMS fitness technology

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Hardware Sales: Sale of CMB devices including MYO HOME (smart home training mirror), MYO PRO (commercial all-in-one), MYO SUIT (wearable EMS suit), MYO LEGGINGS (lower body EMS wear), MYO PET (pet muscle therapy device), MYO BAND (wrist/elbow pain relief), and Miracle20 Play (portable device). Primary revenue driver.
2. Equipment Leasing (MYO Lease Program): Free equipment leasing to partner facilities in exchange for revenue sharing on usage fees. Reduces partner upfront costs while building recurring revenue through service network expansion.
3. Usage/Subscription Fees: Revenue from partner facility usage fees, app subscriptions, and contactless PT services via KakaoTalk. Portion shared with partner facilities and trainers.
4. B2B Enterprise Sales: Direct sales to hospitals, rehabilitation centers, and medical institutions for clinical and therapeutic applications. Targeting expansion in medical device market.
5. Channel/Reseller Revenue: Distribution partnerships including Ceragem US, InBody, Meituan Dianping China, European distributors (6 countries), and regional partners.

Go-to-market motion3 records

Distribution channels8 records

Marketing channels8 records

Core offering

M2WENTY (엠투웬티, also known as M20) designs, manufactures, and sells Electrical Muscle Stimulation (EMS) hardware devices built on its proprietary CMB (Core Muscle Booster) medium-low frequency technology. The product portfolio includes FDA-approved MYO HOME and MYO PRO smart mirror training systems, MYO SUIT and MYO LEGGINGS EMS wearables, MYO PET (pet EMS device), MYO Band, and Miracle20 Play portable trainer, accompanied by a MYO mobile application for health data tracking.

Product overview

M2WENTY (엠투웬티) offers a smart healthcare platform centered on CMB (Core Muscle Booster) medium-low frequency EMS technology. The product portfolio consists of MYO HOME (FDA-approved home training smart mirror with 27-inch display), MYO PRO (43-inch commercial all-in-one healthcare mirror), MYO SUIT (full-body EMS suit), MYO LEGGINGS (lower body EMS leggings), MYO PET (pet patella care device), MYO Band (pain relief device), and Miracle20 Play (portable home training device). These products share CMB technology for muscle stimulation while serving different use cases: home fitness, commercial facilities, wearable exercise, and pet healthcare. The ecosystem is unified through the MYO mobile application for health data management.

Differentiator

Problem solved

Functional benefit

Brands

• Miracle 20: Brand renewal name for MYO HOME, MYO PRO, MYO SUIT, and MYO LEGGINGS product lines, announced August 2024
• MYO
• CMB (Core Muscle Booster)
• Esoco Fit
• MYO Coin

Products and services

• MYO HOME FDA-approved smart home training device combining a 27-inch full-length smart mirror with CMB medium-low frequency EMS technology, enabling muscle-strengthening workouts, body composition analysis, skeletal balance measurement, and trainer-guided video content. Designed for home users seeking fitness without joint strain.
• MYO PRO All-in-one 43-45 inch commercial interactive mirror combining EMS, in-body composition analysis, and scale functionality with body composition measurement, skeletal analysis, and turtle neck posture correction. Designed for fitness centers, yoga studios, nursing homes, and rehabilitation hospitals.
• MYO SUIT Full-body CMB suit stimulating all 16 major muscle groups through medium-low frequency EMS, with easy wear/remove design, machine-washable fabric, and adjustable intensity settings per muscle area for indoor and outdoor use.
• MYO LEGGINGS Specialized EMS leggings with 16 pads targeting hips, pelvis, upper belly, lower belly, waist, thighs, and calves for abdominal and lower body workouts using CMB technology.
• MYO PET Mid-low frequency EMS exercise device for dogs, designed to prevent patellar luxation and provide rehabilitation exercise using a TENS therapy signal system. Received US FDA CLASS2 approval.
• MYO Band Wrist and elbow pain relief device using EMS technology for targeted muscle stimulation and pain management.
• Miracle20 Play 21.5-inch portable stand-type home training device launched in October 2024, featuring CMB technology in a compact form factor for flexible home use.
• MYO Application Mobile application for MYO users enabling health data tracking including body composition, skeletal balance, and exercise history. Compatible with both MYO PRO and MYO HOME for unified health monitoring.

Quantifiable outcome

• Experimental group showed no muscle volume reduction (slight increase) vs 10.469% reduction in control group after 2 weeks of post-surgery immobilization
• +2 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature8 records

Partnerships

Twelve partnerships are on record, tiered core, strategic, minor and regional.

• Johns Hopkins University Medical SchoolcoreStrategic or Co-development Partner · 1 March 2026Technical Strategy Advisory Board (SAB) agreement with Johns Hopkins Medical School research team. Strengthens global research collaboration and provides scientific validation for medium-low frequency EMS technology.
• Hyper Life CarestrategicStrategic or Co-development Partner · 1 November 2024MOU for creating senior total life care ecosystem. Expands healthcare services for elderly population.
• ISECommerce (WizWeed)coreChannel Partner/ Reseller/ Distributor · 1 August 2024Exclusive distribution agreement for Miracle 20 brand (renamed product line). Products available through WizWeed platform. Brand renewal from MYO to Miracle 20.
• International Pet Education Cultural Institute (국제 반려동물 교육 문화원)minorGTM or Marketing Partner · 1 June 2024MOU for 'Don't Hurt, MYO' project on pet patella luxation prevention. Strategic partnership with pet education organization.
• InBodycoreStrategic or Co-development Partner · 1 May 2024Collaboration on domestic and international sales of MYO HOME. InBody's body composition analyzer replacing M20's proprietary analyzer in MYO devices. Integration planned for second half 2024 launch. Demonstrates MYO HOME's platform potential recognized by leading health measurement company.
• Ceragem US SubsidiarycoreChannel Partner/ Reseller/ Distributor · 1 April 2024Sales partnership for MYO HOME with Ceragem's US subsidiary. M20 established local subsidiary in Los Angeles for coordination. Leverages Ceragem's network of direct stores (15 locations including Wellounge experiential cafe in LA). Focus on US consumer accessibility and local recognition.
• Meituan Dianping (메이투안디엔핑)coreChannel Partner/ Reseller/ Distributor · 1 September 2023Product sales partnership for China market. Meituan Dianping operates O2O platform with ~700 million global members, 5 million vendors, 35 million merchants. Plans to sell MYO HOME through app advertising and live commerce. MYO PET distribution also planned.
• Esoco FitcoreChannel Partner/ Reseller/ Distributor · 1 September 2023Offline diet shop franchise using MYO PRO and MYO HOME devices. Users lie down while device strengthens muscles. 10+ locations in South Korea with 5+ more planned. Expansion to Vietnam (Ho Chi Minh), Washington D.C., and New York. Monthly sales reaching ~$9,000 per location.
• KSB TwogencoreStrategic or Co-development Partner · 1 July 2023Joint R&D partnership for muscular atrophy treatment combining pharmaceutical and medical device approaches. KSB Twogen developing new drugs for muscular diseases; M20 providing medium-low frequency EMS technology. Phase II clinical trials planned for October 2023. Goal of comprehensive muscular atrophy solution.
• Suffolk Group (UAE)regionalGTM or Marketing Partner · 1 March 2023Service partnership MOU for MYO HOME and MYO COIN in UAE market. Middle East digital healthcare market expansion.
• Stand Up TherapeuticsminorStrategic or Co-development Partner · 1 December 2022MOU for co-producing rehabilitation programs using M20's EMS technology.
• European Distributors (6 countries)regionalChannel Partner/ Reseller/ Distributor · 1 January 2019Distributor agreements with 6 European countries totaling 6 billion won (2019). Part of FIBO 2019 exhibition partnerships.

Scale indicators10 records

Recent moves10 records

Expansion highlights7 records

Others

• InBody: InBody is a global leader in professional body composition analyzers used in hospitals, fitness centers, and research. Listed as a partner because InBody's analyzer is integrated into MYO HOME (replacing M20's proprietary analyzer), making it both a strategic supplier and a benchmark for the connected-health-measurement ecosystem M20 participates in.

Emerging players

• Withings: Withings builds connected health devices (smart scales, blood pressure monitors, sleep analyzers) with companion apps for body composition and health tracking. Comparable to M20's MYO HOME smart-mirror + InBody integration story in connected health-measurement, though Withings does not offer EMS.
• Hyperice: Hyperice makes connected muscle recovery and therapy devices (percussive guns, vibration, contrast therapy) widely adopted by professional athletes. Adjacent to M20 in muscle recovery market, with stronger sports/athlete brand but different modality and no EMS-equivalent device.
• Therabody (PowerDot): Therabody's PowerDot line offers portable EMS muscle stimulation for athletes and consumers, paired with broader recovery tech (Theragun). Comparable to M20 in portable EMS use case but broader in product portfolio and stronger consumer brand recognition; serves as both competitor and adjacency.

Broad incumbents

• Omron Healthcare: Omron Healthcare is a global incumbent in home medical devices including TENS/EMS pain management units and connected blood pressure monitors. Overlaps with M20 in EMS/TENS category and home-use medical positioning, but operates as a much broader portfolio player rather than specializing in muscle stimulation.

Direct peers

• Slendertone (BioElectronics): Slendertone makes consumer EMS toning belts and apparel for abdominal and muscle strengthening at home. Closely comparable to M20's MYO LEGGINGS and home EMS value proposition, with similar target customer (home fitness, body shaping) and direct-to-consumer retail model.
• Miha Bodytec: Miha Bodytec (Germany) manufactures full-body EMS training systems (i-motion) for fitness studios and personal trainers. Comparable to M20's MYO PRO commercial all-in-one device and MYO Lease program targeting fitness centers and rehabilitation facilities.
• NeuroMetrix: NeuroMetrix develops FDA-cleared medical electrical neurostimulation devices (e.g., Quell, SENSUS) for pain management and rehabilitation. Comparable to M20's MYO HOME (FDA-approved) and MYO Band in clinical-grade electrical stimulation, regulatory pathway, and physician-prescribed use cases.
• BTL Industries: BTL builds EMS-based body sculpting and rehabilitation devices (e.g., EMsculpt) sold to clinics, medspas, and physical therapy practices globally. Comparable to M20 in electrotherapy technology, medical/clinical positioning, and B2B distribution to hospitals and wellness facilities.
• Compex (DJO Global): Compex, owned by DJO Global, is a leading brand in consumer and professional EMS muscle stimulation devices for training, recovery, and rehabilitation. Directly comparable to M20's MYO HOME, MYO PRO, and MYO SUIT lines in core EMS functionality, target athlete/fitness user, and B2B fitness-facility channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@myom2056
• Facebookfacebook.com/M20.MYOMALL
• Instagraminstagram.com/m20_myo

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about M2WENTY